Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

Markel is streamlining operations, exiting reinsurance by selling its Global Reinsurance unit to a major insurer by August 2025. The move aims to sharpen focus on core specialties, supported by ...